Literature DB >> 18419607

Solar elastosis and presence of mast cells as key features in the pathogenesis of melasma.

R Hernández-Barrera1, B Torres-Alvarez, J P Castanedo-Cazares, C Oros-Ovalle, B Moncada.   

Abstract

Melasma is an acquired hypermelanosis on sun-exposed areas. Its pathogenesis has not been clearly elucidated. Using histochemistry (Giemsa, Verhoeff-van Gieson and Fontana-Masson staining), we evaluated melasma lesions and compared them with nonlesional skin. Skin samples were obtained from lesional and nonlesional facial skin of 27 patients with melasma, and biopsies were also taken from normal control subjects. Mast cells and solar elastosis areas were evaluated using a computer-assisted image-analysis program. Lesional skin had abundant elastotic material compared with nonaffected skin (13.3 +/- 2.8% vs. 10.2 +/- 2.9%, P < 0.001). Mast cells were more prominent in the elastotic areas of melasma skin (173 +/- 57% vs. 145 +/- 57%, P = 0.04). Melasma could be a result of a cumulative sun exposure, in a microenvironment of cutaneous photoageing in which inflammatory cells, particularly mast cells, play a key role.

Entities:  

Mesh:

Year:  2008        PMID: 18419607     DOI: 10.1111/j.1365-2230.2008.02724.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  16 in total

1.  What should be considered in treatment of melasma.

Authors:  Hee Young Kang; Jean-Paul Ortonne
Journal:  Ann Dermatol       Date:  2010-11-05       Impact factor: 1.444

2.  In vivo multiphoton microscopy of melasma.

Authors:  Griffin Lentsch; Mihaela Balu; Joshua Williams; Sanghoon Lee; Ronald M Harris; Karsten König; Anand Ganesan; Bruce J Tromberg; Nirmala Nair; Uma Santhanam; Manoj Misra
Journal:  Pigment Cell Melanoma Res       Date:  2018-12-21       Impact factor: 4.693

3.  Sebocytes contribute to melasma onset.

Authors:  Enrica Flori; Arianna Mastrofrancesco; Sarah Mosca; Monica Ottaviani; Stefania Briganti; Giorgia Cardinali; Angela Filoni; Norma Cameli; Marco Zaccarini; Christos C Zouboulis; Mauro Picardo
Journal:  iScience       Date:  2022-02-04

4.  A Double-Blind, Randomized Clinical Trial of Niacinamide 4% versus Hydroquinone 4% in the Treatment of Melasma.

Authors:  Josefina Navarrete-Solís; Juan Pablo Castanedo-Cázares; Bertha Torres-Álvarez; Cuauhtemoc Oros-Ovalle; Cornelia Fuentes-Ahumada; Francisco Javier González; Juan David Martínez-Ramírez; Benjamin Moncada
Journal:  Dermatol Res Pract       Date:  2011-07-21

5.  Skin parameter map retrieval from a dedicated multispectral imaging system applied to dermatology/cosmetology.

Authors:  Romuald Jolivot; Yannick Benezeth; Franck Marzani
Journal:  Int J Biomed Imaging       Date:  2013-09-18

Review 6.  Melasma: a clinical and epidemiological review.

Authors:  Ana Carolina Handel; Luciane Donida Bartoli Miot; Hélio Amante Miot
Journal:  An Bras Dermatol       Date:  2014 Sep-Oct       Impact factor: 1.896

Review 7.  Heterogeneous Pathology of Melasma and Its Clinical Implications.

Authors:  Soon-Hyo Kwon; Young-Ji Hwang; Soo-Keun Lee; Kyoung-Chan Park
Journal:  Int J Mol Sci       Date:  2016-05-26       Impact factor: 5.923

8.  The treatment of melasma by silymarin cream.

Authors:  Tagreed Altaei
Journal:  BMC Dermatol       Date:  2012-10-02

Review 9.  Acquired hyperpigmentations.

Authors:  Tania Ferreira Cestari; Lia Pinheiro Dantas; Juliana Catucci Boza
Journal:  An Bras Dermatol       Date:  2014 Jan-Feb       Impact factor: 1.896

10.  Safflospermidines from the bee pollen of Helianthus annuus L. exhibit a higher in vitro antityrosinase activity than kojic acid.

Authors:  Phanthiwa Khongkarat; Rico Ramadhan; Preecha Phuwapraisirisan; Chanpen Chanchao
Journal:  Heliyon       Date:  2020-03-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.